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ELECTRICALLY CONTROLLED RELEASE OF DOPAMINE 
FROM NANOPOROUS CONDUCTING POLYMERS 
Michael Freedman, BPhil 
University of Pittsburgh, 2010 
 
 Conducting polymers are synthesized on electrode surfaces, conduct electricity, 
and can incorporate different molecules. These properties make them ideal for 
biocompatible application to interface with the nervous system, particularly for drug 
release. This thesis describes the development of system based on nanoporous conducting 
polymers for the controlled release of dopamine. Polypyrrole, a conducting polymer, was 
demonstrated to release the neurotransmitter dopamine when electrically stimulated. 
Dopamine release from nanoporous and non-nanoporous polypyrrole films was 
characterized. Diffusion from unstimulated polypyrrole accounts for much of the 
dopamine release, while a fraction of the dopamine was released in a controllable fashion 
when the polypyrrole film was stimulated. Dopamine was retained by holding the 
releasing electrode at a negative potential. Dopamine release was quantified by fast-scan 
cyclic voltammetry using carbon-fiber microelectrodes.  
Successful controlled release of dopamine from conducting polymer films is 
promising for treatment of neurological conditions characterized by low dopamine levels, 
neuroscience research investigating the effects of neurotransmitters on network activity, 
and it also serves as a model system for controlled release of other similar molecules of 
pharmaceutical interest. 
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1.0 BACKGROUND 
 
1.1 Overview 
 Advances in smart biomaterials research have made great strides in solving some 
of the most challenging medical dilemmas. Bioactive conducting polymers are one such 
area of research that holds great potential. They are synthesized on conductive substrates, 
are electrically conductive, and their highly customizable properties make them ideal for 
biomedical applications. Varying the substrate surface and method of synthesis can tailor 
conducting polymers to have a wide range of morphologies and surface structures. One 
unique aspect of their mechanism of synthesis is the inherent capability of incorporating 
different molecules including proteins and drugs, and careful choice of these molecules 
can customize the polymer for highly specialized bioactivity and increased 
biocompatibility. Conducting polymers undergo a characteristic charging and discharging 
of their backbone, and this reversible reaction is ideal for mediating controlled drug 
release.  
 My research has been focused on optimizing this mechanism to maximize the 
capacity and control the release of dopamine from nanoporous conducting polymers. 
Localized, controlled release of dopamine is highly desirable for the treatment of a range 
of neurological disorders characterized by low extracellular dopamine concentrations, 
most notably Parkinson’s disease. The development of a conducting polymer system to 
release dopamine in a controllable fashion has applications for the release of a variety of 
drugs that share similar chemical properties. 
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1.2 Conducting Polymers 
 Conducting polymers are large macromolecules characterized by monomeric units 
connected by a conjugated backbone. This backbone is comprised of atoms with parallel 
p orbitals, constituting a delocalized pi system across which electrons can flow freely. 
This class of polymers includes polyacetylenes, polyanilines, polythiophenes, and 
polypyrroles (Figure 1). Polymerization can occur via either chemical or electrochemical 
mechanisms [1]. Electropolymerization has many advantages over chemical synthesis 
pathways, including ease of synthesis, customizability, and polymer synthesis directly on 
the conductive surfaces of electrodes.  
Polypyrrole (PPy) is the conducting polymer of interest in this thesis and its 
mechanism of electropolymerization has been studied extensively [2, 3]. When an 
oxidative potential is applied to pyrrole (Py) monomers in solution, the monomer will 
undergo oxidation to a delocalized radical cation. This is followed by radical coupling 
dimerization and further oxidative polymerization until the oligomer exceeds a critical 
length, loses solubility in solution, and deposits on the anode. Once this occurs, 
polymerization at the anode surface occurs more easily and at lower potential, and 
negatively charged counterions called dopants are incorporated into the polymer film to 
balance the positive charge on the PPy backbone [1-4]. During these simultaneous 
processes of electrochemical synthesis and polymer doping, the amount of dopant 
incorporated can range between 30 – 50% of the total weight of the polymer film [1, 2]. 
The simplified electropolymerization and doping mechanism is illustrated in Figure 2, 
and outlined in detail by John and Wallace [3]. 
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Figure 1. Structures of conducting polymers. 
 
 
 
Figure 2. Oxidative electropolymerization and doping of PPy (n = the number of Py 
monomers per dopant molecule, noted as A
-
). 
 
 
 Choice of dopant molecule has profound effects on the adaptability of the 
resulting polymer film, especially for biomedical applications [5-16]. One particularly 
appealing development has been the incorporation, both irreversible and reversible, of 
large biomolecules as dopants in conducting polymer films to optimize their bioactivity 
for specific functions. In this regard, conducting polymer films have been doped with 
heparin [5, 6], hyaluronan [7], silk-like polymer with fibronectin fragments, and peptide 
sequences from laminin [8, 9]. Integration of biomolecules into conducting polymer films 
does not compromise their biophysical functionality or the electrically active properties 
of the polymer. 
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 The properties of conducting polymers that make them highly attractive 
candidates for biomedical applications are not limited to their capacity for 
customizability. Conducting polymers such as PPy have been shown to have excellent 
inherent biocompatibility, low electrical impedance, and as the name suggests, the ability 
to conduct electricity [7, 10-14]. These characteristics and their ease of synthesis on 
electrodes make conducting polymers ideal for integration with the nervous system. Past 
studies have integrated brain-derived neurotrophic factor (BDNF) and neurotrophin-3 
(NT-3) in conducting polymer films to preserve spiral ganglion neurons after hearing loss 
[15-17]. 
 
1.2.1 Drug Release via Reversible Oxidation-Reduction Reaction 
 One of the most attractive properties of conducting polymers for biomedical 
applications stems from their reversible oxidation-reduction (redox) reaction. Upon 
electrical stimulation, the polymer is oxidized (loses electrons) or reduced (gains 
electrons) and the backbone becomes charged or neutral (Figure 3). Subsequently, ions 
flow into or out of the polymer film to maintain electrostatic charge balance [1]. The 
ionic flux is accompanied by changes in volume of the polymer as it expands and 
contracts [10]. 
 The PPy redox reaction drives several processes. In the case of small, mobile 
anionic dopants, the discharge of the polymer backbone during reduction causes the 
electrical association between the polymer and the anionic doping molecules to be 
broken, and the dopant molecules will be released. The ultimate result is controlled 
release of the dopant molecules through electrical stimulation of the polymer [18]. This 
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mechanism of anionic dopant release is well studied, and a wide variety of compounds 
with different clinical applications have been released from PPy films in this fashion. 
They range from fluorescein and Fe(CN)6
4- 
[19-21] to glutamate [21], CNQX [4], 
salicylate, naproxen [22], ATP [23, 24], and dexamethasone [18]. The mechanism that 
drives this release is detailed below (Figure 3, top). 
 The polymer redox reaction also drives motion of cations [1, 25-27]. When the 
polymer is doped with a large, polyanionic dopant such as polystyrene-sulfonate (PSS), 
the dopant cannot leave the polymer film when the backbone is reduced due to its large 
size and intricate integration with the polymer. As a result, cations from the solution are 
incorporated into the polymer to balance the negative charge of the polyanion. This step 
is referred to as binding the cation to the polymer film. Oxidation of the polymer then 
allows the cation to be released into solution [1]. By this mechanism, release of cationic 
compounds can also be controlled by the application of electrical stimuli to the polymer 
film. Cationic release has been demonstrated for chlorpromazine, dimethyldopamine, and 
dopamine, all of which bear positive charge [25-27]. This release mechanism is the 
underlying process that makes the research presented in this thesis possible. 
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Figure 3. Release mechanism for small, mobile dopants of PPy (top), and release 
mechanism of cationic ions for PPy with large, immobile dopants (bottom). Oxidation is 
indicated on the left side, and reduction is on the right side (A
-
 denotes anionic dopant, 
X
+ 
denotes cation). Adapted from [1]. 
 
 
1.2.2 Effects of Morphology 
 Properties of conducting polymers are heavily influenced by surface morphology. 
Rougher polymer films increase the available surface area to interface with nervous tissue 
in vivo. This results in a decrease in impedance combined with a more intimate contact 
between the electrode and surrounding neural tissue, both of which are highly desirable 
for improving electrode performance in neural recording applications [14].  Changes in 
polymer structural morphology can also greatly affect drug release processes. When the 
underlying substrate electrode morphology exhibits increased surface roughness and high 
surface area, there is an increase in drug load per area and drug is more efficiently 
released for a given electrical stimulus [28]. Nanoscale structures based on the concept of 
a drug reservoir, such as nanotubes and nanopores, have also been studied as ways of 
increasing drug capacity and improving the controllability of release from conducting 
polymer films [10, 19, 29]. Nanoporous structures are the focus of investigation in this 
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thesis due to the increased drug capacity afforded by a nanoporous structure. 
Additionally, a semi-permeable polymer cap could add further controllability to prevent 
diffusion [19, 29]. 
 
1.3 Dopamine: Structure and Function 
1.3.1 Biophysical Properties and Translatability 
 Dopamine is an important neurotransmitter with a variety of functions in the 
body. In the central nervous system (CNS), it is synthesized by dopaminergic neurons, 
most prevalent in the substantia nigra and ventral tegmental area within the 
mesencephalon, as well as the hypothalamus within the diencephalon [30, 31]. As a 
modulatory CNS neurotransmitter, dopamine is involved in neural mediation of a range 
of system functions including motor control, emotional regulation, reward, motivation, 
cognition and endocrine function [32]. In the hypothalamus, dopamine is a neurohormone 
that serves to regulate pituitary hormones such as prolactin, vasopressin, and oxytocin 
[33, 34] and has also been connected to regulation of food intake [35]. Dopamine is also 
synthesized in the adrenal medulla, where it serves as a precursor in the synthesis of the 
hormones norepinephrine and epinephrine (adrenaline). The biosynthesis pathway of 
dopamine, as depicted in Figure 4, is extremely well studied. It is synthesized from the 
amino acid tyrosine which forms its precursor L-3,4-dihydroxyphenylalanine (L-DOPA) 
[32].  
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Figure 4. Biosynthesis pathway of catecholamines. Adapted from [36]. 
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Dopamine is classified as a primary monoamine within a category of compounds 
known as catecholamines. Catecholamines are characterized by a molecular structure that 
includes a 1,2-dihydroxybenzene ring, an ethyl chain and a terminal amine group. 
Dopamine, norepinephrine, and epinephrine share these structural characteristics. In pH 
neutral solution (~7.4), the primary amine group on dopamine favors protonation, 
yielding a species bearing positive charge (Figure 5) [37, 38]. Its small cationic structure 
outlines dopamine as a candidate for controlled release from conducting polymers via the 
cationic release mechanism (Figure 3, bottom). 
 
 
Figure 5. The protonated species (right) is favored in neutral pH. 
 
 
 One characteristic reaction of dopamine and other catecholamines is their ability 
to undergo autoxidation. In this reaction, dopamine reacts with molecular oxygen in 
solution or in vivo to form o-semiquinones and quinones, ultimately ending in 
polymerization and aggregation of insoluble melanins [39-42]. These mechanisms are 
mapped in great detail by Graham et al [43]. Dopamine undergoes autoxidation the most 
rapidly of the catecholamines in question [39]. In tissue, this radical oxidation is thought 
to have cytotoxic effects [39, 44]. In spectrophotometric quantification of dopamine in 
vitro, autoxidation causes the solution to darken as dopachrome compounds polymerize 
[40]. This greatly alters the observed absorption spectrum over time, rendering 
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spectrophotometric methods of dopamine quantification to be of little value. The 
oxidation of dopamine into dopamine o-quinone can be simplified to a two-electron 
transfer mechanism (Figure 6). 
 
 
Figure 6. Interconversion between dopamine and dopamine o-quinone. 
 
 
 While the oxidation of dopamine to the quinone and subsequent polymerization 
reactions are undesirable for both in vivo cytotoxic effects and in vitro 
spectrophotometric quantification, the initial reversible mechanism has a characteristic 
electrochemical signature that makes it ideal for electrochemical detection. 
Electroanalytical methods of dopamine characterization will be discussed in further detail 
in section 1.4. 
 As a small positively charged molecule, dopamine is similar in structure to a wide 
class of catecholamines. Controlled release of molecules such as epinephrine, 
norepinephrine, and other catecholamines could also potentially be mediated by the same 
mechanism via conducting polymers, opening a window of new treatment options for 
diseases influenced by catecholaminergic pathways. Quaternary ammonium salts are 
another class of small biologically active molecules that bear positive charge, the most 
well known of which is the neurotransmitter acetylcholine. Thus, application of an 
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electrically controlled system to release acetylcholine could have profound implications 
for treatment of Alzheimer’s disease, myasthenia gravis, and other diseases affected by 
cholinergic processes of the nervous system. Subsequently, successful binding and 
release of dopamine from conducting polymer films serve as a model system applicable 
to a very large range of pharmaceutically relevant drugs.  
 
1.3.2 Clinical Applications for Controlled Dopamine Release 
 Many neurological disorders are linked to reduced dopaminergic activity in the 
central nervous system. For example, affective disorders such as depression have been 
linked to reduced dopamine turnover and transmission [32, 45, 46]. Dopamine deficiency 
in the pathology of epilepsy and Parkinson’s disease has also been studied extensively. 
Parkinsonian neurodegeneration is characterized by the loss of dopaminergic neurons in 
the substantia nigra, and results in significant reductions in extracellular dopamine in the 
striatum, the region to which these neurons normally project [47]. Additionally, 
hypoactivity of striatal dopamine is thought to contribute to the development of epilepsy 
(epileptogenesis), and a substantial amount of research supports the hypothesis of that 
dopamine has substantial antiepileptic properties [48]. 
 The primary treatment option for patients diagnosed with Parkinson’s disease is 
systemic administration of levodopa (L-DOPA) [49]. Levodopa is capable of crossing the 
blood-brain barrier, a highly selective barrier that separates blood in the systemic 
circulation from the cerebral spinal fluid of the central nervous system. Therefore, 
peripherally administered levodopa can circulate through the bloodstream and cross into 
the CNS. As a metabolic precursor to dopamine (Figure 4), levodopa in the CNS is 
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metabolized to dopamine, thereby replenishing dopamine stores in the brain [50]. While 
there is evidence that levodopa either slows the progression of Parkinson’s disease 
overall or slows the exacerbation of symptoms, there are a multitude of undesirable 
effects of long-term levodopa treatment [51]. Common adverse side effects include 
increased dyskinesia, hypertonia, infection, headache, and most prominently, hypotension 
and nausea [50, 51]. Chronic levodopa treatment can also reduce the effectiveness of 
individual doses, as well as lead to motor complications due to altered firing patterns of 
neurons in the basal ganglia [49]. 
 Deep brain stimulation (DBS) is another clinical treatment option for both 
patients with Parkinson’s disease and patients with epilepsy. In deep brain stimulation, 
electrodes connected to a stimulation apparatus are surgically implanted in the brain. 
They chronically stimulate either the subthalamic nucleus (STN) or the internal globus 
pallidus (GPi) at frequencies from 30 – 60 Hz [52, 53]. In patients with Parkinson’s 
disease, DBS has been shown to drastically improve motor symptoms, speech, and 
overall quality of life while reducing the need for dopaminergic treatment [52].  While 
the mechanism by which DBS accomplishes these improvements is unknown, therapeutic 
benefits are also afforded to epileptic patients undergoing DBS treatment including 
substantial reduction in seizing [53, 54]. 
 Electrically controlled dopamine release is potentially another avenue of 
treatment of neurological disorders characterized by reduced dopaminergic activity. 
Conducting polymer based release systems are synthesized directly on electrode surfaces, 
making integration with pre-existing DBS apparatuses highly feasible. Localized delivery 
of dopamine from an electrode implanted in the nervous tissue of the brain also 
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eliminates the need for systemic administration of levodopa, thereby reducing 
undesirable effects while still achieving the clinical goal of replenishing depleted 
dopamine levels. 
 
1.4 Electrochemical Detection of Dopamine 
1.4.1 Introduction to Electroanalytical Techniques 
 The field of electrochemistry can be defined very broadly, describing any process 
that involves the transfer of electrons. This ranges from the corrosion of metal, batteries 
powering electrical devices, and industrial processes such as electroplating. The 
fundamental relationship of electron transfer in oxidation-reduction (redox) reactions is 
described by a half reaction: 
 O + ne
-
 ↔ R Equation 1 
The oxidized species (O) and the reduced species (R) differ by n electrons (Equation 1). 
Each half reaction has a characteristic potential (voltage) at which this reaction occurs. In 
electrochemical systems, two half reactions occurring at separate electrodes are linked 
together, and they respond to the potential difference at the electrode - electrolyte 
interface. Interest is typically focused on one of these half reactions, occurring at an 
electrode called the working electrode. The potential of the working electrode must 
therefore be normalized by the known potential of the other half reaction occurring at an 
electrode called the reference electrode [55]. The international standard for reference 
potential of electrochemical cells is characterized by the half reaction of 2H
+ 
reducing to 
diatomic hydrogen occurring at a normal hydrogen electrode (NHE), but other reference 
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electrodes such as silver-silver chloride (Ag/AgCl) and saturated calomel electrodes 
(SCE) are common (Table 1) [55]. 
 
Table 1. Common Reference Electrode Potentials and Half Reactions. 
Reference Electrode Reaction Potential (V) 
NHE 2H
+
  +  2e
-
 ↔  H2 0 
SCE Hg2Cl2  +  2e
-
 ↔ 2Hg  +  2Cl- 0.242 (in Saturated KCl) 
Ag/AgCl AgCl  +  e
-
 ↔ Ag  +  Cl- 0.197 (in Saturated KCl) 
 
 Applying a potential to the working electrode generates a response within the 
electrochemical cell called a current. In electrochemical systems, this flow of electrons 
exists as either faradaic or non-faradaic current. Faradaic current describes the physical 
transfer of electrons between the electrode and a species in solution, whereas non-
faradaic current describes all other processes that can occur with a change in potential 
and cause a transient flow of current, including adsorption/desorption and capacitive 
charging of the electrical double layer (adsorbed solvent molecules and ions). Direct 
measurement of faradaic current is a useful electroanalytical tool to study redox 
reactions, while non-faradaic (capacitive) current contributes to the background signal. 
 The two conventional setups of electrochemical cells are two-electrode and three-
electrode configurations and are used in different circumstances. The two-electrode 
configuration consists of the working electrode and the reference electrode. Current flows 
between the two electrodes, and voltage is measured across them. This is used in 
solutions with less resistance, and can be used in highly resistive solutions with a 
microelectrode as the working electrode (Figure 7A). Three-electrode systems include an 
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auxiliary (or counter) electrode as well, and are typically for systems with high solution 
resistance. In this setup, current flows between the working and auxiliary electrodes, but 
voltage is measured across the reference and working electrodes (Figure 7B). Three 
electrodes also allow for improved control of potential between the reference and the 
working electrodes by removing the reference electrode from the current loop [56]. 
 
A.  
B.   
Figure 7. Two-electrode (A) and three-electrode (B) electrochemical cells [55]. 
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1.4.2 Fast-Scan Cyclic Voltammetry 
 Cyclic voltammetry is a powerful analytical tool used for a variety of purposes. It 
has been used extensively to identify and quantify concentrations of biologically 
important analytes. In this process, the potential of the working electrode is linearly 
ramped above the oxidation potential and below the reduction potential of the analyte of 
interest, and the resulting current is recorded (Figure 8). When the potential applied is 
sufficient to drive the transition of the analyte to the oxidized or reduced state, the current 
is proportional to the number of molecules electrolyzed [57]. The results of cyclic 
voltammetry are displayed graphically in a cyclic voltammogram, with current as a 
function of potential applied (Figure 9). The maximal current at the potential of oxidation 
or reduction is called the peak current (ip). 
 
 
Figure 8. Voltage as a function of time in cyclic voltammetry. 
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Figure 9. A model cyclic voltammogram, showing current as a function of potential. ipc 
and ipa represent cathodic and anodic peak currents, corresponding to reduction and 
oxidation, respectively, of the electrochemical species. Epc and Epa represent the 
potentials at which these peak currents occur. 
 
 
The rate at which the potential is swept is called the scan rate (ν), and can 
profoundly affect the cyclic voltammogram. Cyclic voltammetry performed at high scan 
rates is called fast-scan cyclic voltammetry (FSCV). The relationship between peak 
current and scan rate depends on the geometry of the electrode, the subsequent mode of 
transport that dominates, and structure of the electrode-electrolyte interface. For example, 
ip is linear with respect to ν for a thin layer of adsorbed species [58], while it is linear 
with respect to ν1/2 for linear diffusion-mediated processes at planar electrodes [55]. 
Additionally, though the peak current, ip, indicates the faradaic current from the oxidation 
of the analyte of interest, the total current is the sum of faradaic (redox) and non-faradaic 
(capacitive charging) currents. In cyclic voltammetry, the non-faradaic current is 
proportional to the scan rate [55]. Therefore, as scan rate increases, the background 
current gets substantially larger. The conventional method for eliminating this 
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background signal is called background subtraction (Figure 10). A cyclic voltammogram 
is acquired in the solvent without the analyte of interest, and the current of this 
voltammogram is subtracted from subsequent cyclic voltammograms that contain the 
peak current of the oxidized (or reduced) analyte. 
 
A.   B.   C.  
Figure 10. Background Subtraction. A, B, and C refer to the background signal alone, the 
background and the analyte signal (dopamine), and the background subtracted curve 
respectively. 
 
 
1.4.3 Carbon-Fiber Microelectrodes for Catecholamine Detection 
Reduction of the size of electrodes used in voltammetric processes dramatically 
improves the quality of electrochemical data. Microelectrodes have much larger current 
density than larger electrodes because of radial and perpendicular diffusion. Fast-scan 
cyclic voltammetry can reduce the contribution of capacitive (non-faradaic) current at 
microelectrodes, but background subtraction is still useful [55, 59]. The small double-
layer capacitance of microelectrodes allows the potential of the electrode to change 
rapidly. When used in conjunction with FSCV, microelectrodes can achieve very high 
spatial resolution that is ideal for quantifying dynamic changes of catecholamines [60]. 
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Sensitivity and selectivity of FSCV using microelectrodes can be further improved with 
digital filtering and ensemble averaging processes [61, 62]. 
 
1.5 Specific Aims 
 This investigation has several specific aims for the development of a conducting 
polymer based dopamine release system: 
(1)  To bind dopamine to conducting polymer film 
(2) To release dopamine in a controllable fashion upon application of an 
electrical stimulus 
(3) To maximize dopamine capacity of conducting polymer film by 
implementing a nanoporous structure 
(4) To minimize diffusion of dopamine from conducting polymer film by 
incorporating a semi-permeable cap 
(5) To retain molecular structure and therefore preserve biological 
functionality of dopamine released from conducting polymer film 
 The following sections describe in detail how each of these specific aims is 
approached and the strategies, experimental techniques, and evaluation methods 
implemented in their execution. 
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2.0 EXPERIMENTAL 
 
2.1 Preparation of Release Electrodes 
 Glassy carbon disk (GCD) electrodes (3 mm diameter, 6 mm outer diameter 
including teflon insulating sheath, CH Instruments) were roughened with fine sandpaper 
and polished sequentially with 1.0 µm and 0.05 µm alumina slurries. They were then 
ultrasonically washed with water and ethanol for 5 minutes. The GCD electrodes were 
then set aside for non-nanoporous (i.e. flat) conducting polymer films as described in the 
next section, or pretreated electrochemically to make the surface more hydrophilic for the 
process of synthesizing nanoporous conducting polymer films. Electrochemical 
pretreatment of GCD electrodes consisted of chronoamperometry (constant voltage) at -
1.8V for 200 seconds, followed by five cycles of cyclic voltammetry between 0.3 and 1.3 
V at a scan rate of 100 mV/s in a solution of phosphate buffered saline (PBS). This 
process oxidizes the surface of the GCD electrodes, making them more hydrophilic.  
Following electrochemical pretreatment, 5.0 µL of a 1.0% (w/v) polystyrene 
nanobead suspension (mean diameter 46 ± 2.0 nm, Duke Scientific) was pipetted onto the 
GCD electrode surface. The nanobeads serve as a template through which the conducting 
polymer film will polymerize. The GCD electrodes were placed vertically to dry. When 
completely dry, the GCD electrodes with the polystyrene nanobead template were heated 
at 60˚C for 15 minutes and then set aside to cool to room temperature.  
All electrochemical preparations of GCD electrodes were performed on a Gamry 
Potentiostat, FAS2/Femtostat (Gamry Instruments) with Gamry Framework software. A 
three-electrode setup was used with the GCD electrode as the working electrode, a 
21 
 
platinum wire counter electrode and a silver/silver chloride (Ag/AgCl) reference 
electrode containing 1.0 M KCl.  
 
2.2 Electropolymerization of Conducting Polymer Films 
 Conductive PPy films were electrochemically synthesized on either flat GCD 
electrodes or GCD electrodes modified with the polystyrene nanobead template. For 
electropolymerization, GCD electrodes with or without the nanobead template were 
immersed in a solution of 0.05 M pyrrole (98%, Sigma-Aldrich, vacuum distilled), 0.03 
M poly(sodium styrene-4-sulfonate) (PSS) in deionized water. Using the same three-
electrode setup described in the previous section, constant current of 311 µA was applied 
for 100 seconds to each of the GCD electrodes (Figure 18). 
 The PPy/PSS films synthesized through the nanobead template were then rinsed 
with deionized water and left in toluene overnight to dissolve the polystyrene nanobeads, 
leaving a nanoporous structure. Some of these GCD electrodes modified with nanoporous 
PPy/PSS were further modified with a semi-permeable conducting polymer “cap” 
intended to prevent diffusion of DA from the nanoporous film. The cap was 
electropolymerized via cyclic voltammetry starting at 1.0 V and sweeping between 0.5 V 
and 1.2 V at a scan rate of 25 mV/s employing the same three-electrode setup. Scanning 
electron micrograph (SEM) images included below show examples of the microstructure 
of each of the stages of synthesis of similarly prepared capped nanoporous PPy films 
(Figure 11) [29]. The final resulting groups of modified GCD electrodes used include 
those modified with flat PPy/PSS, nanoporous PPy/PSS, and capped nanoporous 
PPy/PSS films, schematically illustrated in Figure 12. 
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Figure 11. SEM images of (a) the polystyrene nanobead template, (b) the nanoporous 
PPy film remaining after the nanobeads were dissolved away, (c) the nanoporous PPy 
film covered with an additional capping layer of PPy, and (d) a cross-sectional image of 
the interface between the nanoporous PPy (white arrows) and the additional capping layer 
of PPy (black arrows) [29]. 
 
 
 
Figure 12. Electropolymerization scheme illustrating preparation of each of the three 
polymer films. (A) PPy/PSS films are polymerized with constant current at 311 µA for 
100 seconds either through the nanobead template or on the bare GCD electrode surface 
in a solution of 0.05 M Py and 0.03 M PSS. (B) Polystyrene nanobeads are dissolved by 
toluene overnight, leaving nanoporous PPy/PSS. (C) PPy/PSS cap is polymerized over 
nanoporous PPy/PSS via cyclic voltammetry in a solution of 0.05 M Py and 0.03 M PSS. 
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2.3 Preparation of Carbon-Fiber Microelectrodes 
 Carbon-fiber microelectrodes (CFMEs) were constructed from single 7 µm 
diameter carbon fibers (T650, Cytec Carbon Fibers LLC) threaded through borosilicate 
capillary tubes (0.75 mm inner diameter, 1.0 mm outer diameter, A-M Systems, Inc). The 
capillary tubes were pulled to a fine point around the carbon fiber using a vertical 
micropipette puller (Narishige) and injected with epoxy (Spurr Epoxy, Polysciences Inc) 
to fix the position of the fiber. The protruding fiber was trimmed to 400 µm, and the 
capillary was filled with mercury (electronic grade, Sigma-Aldrich) to bridge electrical 
contact between the carbon fiber and the tungsten contact wire. CFMEs were sonicated in 
reagent grade isopropanol (Sigma-Aldrich) containing activated carbon (Fisher 
Scientific) for 5 minutes prior to use. 
 
2.4 Calibration of Carbon-Fiber Microelectrodes via Fast-Scan Cyclic Voltammetry 
 CFMEs were calibrated prior to dopamine release. Precalibration serves a dual 
purpose. First, it establishes a relationship between dopamine concentration and peak 
current of the cyclic voltammogram. Additionally, pre-exposing the CFME to dopamine 
prior to the release studies allowed dopamine to adsorb to the CFME to a certain degree 
and thereby minimizing dynamic changes in the sensitivity of the CFME to subsequent 
dopamine adsorption in the release experiments. This is explained in further detail in 
section 3.1. Calibration was performed in a flow cell with gravity-driven concentrated 
10X PBS (154 mM NaCl, 100 mM Na2HPO4, titrated to pH ~7.4 with NaH2PO4). 
Standard solutions for calibration were prepared with dopamine HCl (Sigma-Aldrich). 
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Fast-scan cyclic voltammetry (FSCV) was carried out using an EI 400 high-speed 
bipotentiostat (Ensman Instruments) and the CV Tar Heels v4.3 software package (Dr. 
Michael Heien, Department of Chemistry, Pennsylvania State University). The CFME 
was held at a resting potential of 0 V vs Ag/AgCl reference in a two electrode setup, and 
the potential was swept to +1 V, down to -0.5 V, and back to 0 V at a scan rate of 400 
V/s. Characteristic dopamine oxidation current peaks were observed at ~ +0.6 V, and 
dopamine voltammograms were obtained by background subtraction and sampled at 10 
Hz [63]. 
 
2.5 Cathodic Binding of Dopamine to Conducting Polymer Films 
 Dopamine was cathodically bound to the PPy/PSS modified GCD electrodes 
using the EI 400 bipotentiostat. The PPy/PSS modified electrodes were held at -0.6 V vs 
Ag/AgCl reference electrode and a platinum rod counter electrode for 200 seconds using 
a three-electrode setup in a solution of 0.1 M dopamine HCl (Sigma-Aldrich) in 
deionized water. The resulting polymer film consists of PPy doped with PSS and 
cathodically bound with dopamine, notated PPy/PSS/DA. The dopamine binding 
mechanism is thoroughly described in section 1.2.1.  
 
2.6 Electrically Controlled Dopamine Release 
 Dopamine release from various PPy/PSS films was attempted using a number of 
experimental setups (Figure 4). All setups were performed with the EI 400 bipotentiostat 
running two channels simultaneously against Ag/AgCl reference electrode and platinum 
rod counter electrode in a four-electrode setup (two overlapping three-electrode setups). 
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The CFME was connected to channel A, constantly running the FSCV waveform as 
described in section 2.4, whereas channel B controlled the potential of the GCD electrode 
modified with PPy/PSS/DA. The CFME equilibrated in solution until peak current at DA 
oxidation potential remained stable within ±2 nA. The potential of channel B was toggled 
between -0.3 V, 0 V and +0.3 V vs Ag/AgCl, providing the electrical stimulus that drives 
the controlled release of dopamine from the PPy/PSS/DA films. 
 Due to the setup of the initial configuration, the CFME was initially positioned 
opposite an unmodified platinum disk electrode. The CFME sampled a background 
current from the PBS solution, and then the platinum disk electrode was replaced with the 
GCD electrode modified with PPy/PSS/DA (Figure 13A). This was done to avoid 
acquiring a background signal that contained peaks from dopamine leaking out of the 
PPy/PSS/DA film, which was observed several times. The undesirable net effect would 
be background subtraction of a signal that contained the dopamine electrochemical 
signature as well as the background current, misrepresenting the rest of the release 
profile. The CFME was positioned 250 µm above the surface of the PPy/PSS/DA film, 
and the electrochemical experiments were performed in 100 µL of 1X PBS using 
Ag/AgCl wire as a reference electrode. However, peak currents were observed at 
inconsistent potentials, leading to a revision in the experimental configuration. 
 The revised experimental configuration (Figure 13B) included several major 
changes from the initial setup. To resolve the issue of shifting potentials of peak current, 
a stronger buffer solution, 10X PBS, was used in place of the original 1X PBS, and the 
Ag/AgCl wire reference electrode was replaced with a Ag/AgCl reference electrode in an 
ion-selective membrane containing 10X PBS solution. The revised setup was carried out 
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in a 200 µL droplet on a glass substrate, and required the CFME to be fixed to the side of 
the GCD electrode, greatly increasing the distance between the two electrodes to at least 
2.4 mm. This therefore required more time to observe DA release after each stimulus. 
Additionally, while this configuration allowed CFME equilibration and theoretically 
acquisition of a DA-free background signal, DA was still observed in the equilibration 
profile. These suggest that the experimental configuration required further revision. 
 The final experimental configuration (Figure 13C) separated the CFME and the 
modified GCD electrode to independent micromanipulators. This allowed the CFME to 
fully equilibrate and acquire a pristine background signal before the modified GCD was 
introduced into the system. The modified GCD electrodes were positioned approximately 
1 mm away from the CFME. 
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Figure 13. Evolution of dopamine release experimental configuration 
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3.0 RESULTS 
 
3.1 Carbon-Fiber Microelectrodes 
3.1.1 Calibration 
 Standard solutions of 0.5, 1.0, and 5.0 µM in either 1X PBS or 10X PBS were 
used to calibrate the CFMEs (Figure 14). Direct correlation was established between 
dopamine concentration and background subtracted peak current, and there was limited 
variability between the calibrations of different electrodes. Differences in electrode 
calibration curves were observed between CFMEs calibrated in different solvents (Figure 
15). While the vast majority of CFME calibrations were done in 10X PBS, calibration 
curves from data obtained in CFME calibrations in other solvents (ACSF = artificial 
cerebrospinal fluid) are included for comparison. Calibration curves were also obtained 
for a wider range of concentrations of dopamine, varying from 0.1 µM to 30 µM (Figure 
16). 
 
Figure 14. Peak currents (nA) of dopamine solutions of known concentrations in 10X 
PBS as observed in the flow cell as a function of time (s). The maximal peak current 
generated for each concentration was used for the calibration curve. 
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Figure 15. Calibration curve for electrochemical detection of dopamine in different 
solvents (error bars indicate standard error).  
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A.  
B.  
Figure 16. Calibration curves for electrochemical detection of dopamine displayed across 
a wide range of concentrations (A) and compared with a linear fit when plotted 
logarithmically (B). 
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3.1.2 Equilibration 
 Extensive equilibration behavior was observed as CFMEs reached steady state 
while continuously performing FSCV. The timescale necessary to reach state equilibria 
varied, but typically ran between 10 – 30 minutes. Decaying background current in the 
oxidation region and increasing current in the reduction region of the cyclic 
voltammogram were observed as characteristics of the equilibration process (Figure 
17A). As the CFME equilibrated, the cyclic voltammogram became more stable over 
time. The threshold between the equilibration process of the electrode and the steady-
state condition was defined as the point in time when observed background-subtracted 
peak current at +0.6 V did not exceed ±2 nA over a 200 second period (Figure 18B). 
 
 
 
 
 
 
32 
 
A.  
B.  
Figure 17. (A) Dynamic background-subtracted cyclic voltammogram as the CFME 
equilibrated in 10X PBS. Voltage Point Number (VPN) indicates the potential of the 
CFME as a function of its point of progression in the voltage sweep. Each cycle is 
divided into 1000 increments as the voltage sweeps from 0 to +1.0 V, down to -0.5 V, 
and back to 0 V. (B) Decaying peak current at +0.6 V (VPN ~200), the characteristic 
oxidation potential of dopamine, from Fig. 17A as the CFME equilibrates over time. 
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A.  
B.  
Figure 18. (A) Dynamic background-subtracted cyclic voltammogram after the CFME 
has equilibrated to steady state. Note the difference in scale of the current (+z) axis 
between Figures 17A and 18A. (B) Steady-state peak current from Fig. 18A at +0.6 V, 
the characteristic oxidation potential of dopamine, as a function of time. The current does 
not exceed ±2 nA. 
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3.2 Synthesis and Characterization of PPy/PSS/DA Electrodes 
3.2.1 Electropolymerization of PPy/PSS Films 
 Constant current of 311 µA was applied to either the bare GCD electrodes or the 
GCD electrodes modified with the nanobead template, standardizing current density to 
4.4 mA cm
-2
. The voltage required to maintain the applied current was substantially 
higher for polymerization of PPy/PSS films through the nanobead template than for the 
same electrochemical process on bare GCD electrodes (Figure 19). 
 
 
Figure 19. Average chronopotentiometric potential curves for electropolymerization of 
PPy/PSS films on bare GCD electrodes and GCD electrodes with a nanobead template 
(n=10 per group). 
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3.2.2 Redox Threshold and Stability of PPy/PSS 
 Cyclic voltammetry was performed on flat PPy/PSS films to test the stability of 
the polymer film and to confirm the position of the potentials at which oxidation and 
reduction of the film occur. The oxidation peak occurs slightly below 0 V, and the 
reduction peak appears most prominently at approximately -0.7 V. Many cycles of cyclic 
voltammetry were performed on the polymer film to test its stability over time and 
resilience to charging and discharging (Figure 20). 
 
 
Figure 20. Cyclic voltammogram of flat PPy/PSS film on GCD electrode in 1X PBS 
solution using a three-electrode setup vs Ag/AgCl reference and platinum wire counter 
electrodes (scan rate = 100 mV/s). Several cycles are superimposed to depict the change 
in the response of the PPy/PSS film to repeated charging and discharging. 
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3.2.3 Cathodic Binding of Dopamine to PPy/PSS Films 
 Dopamine, positively charged in 10X PBS (pH ~7.4), was integrated into 
PPy/PSS films via a cathodic binding mechanism. Constant potential was applied at -0.6 
V to the PPy/PSS modified electrode, incorporating dopamine into the conducting 
polymer structure (Figure 21). 
 
 
Figure 21. Amperometric decay as a function of time. Dopamine (0.1 M in deionized 
water) was cathodically bound to nanoporous PPy/PSS films by applying -0.6 V vs 
Ag/AgCl to the PPy/PSS modified electrodes for 200 seconds (n=10). 
 
 
3.3 Effect of Electrical Release Stimulus on FSCV 
 The stimulus control was evaluated for both the flat PPy/PSS and nanoporous 
PPy/PSS modified electrode surfaces. This experiment serves as a control in which no 
dopamine is present anywhere in the system, and an electrical stimulus is applied to the 
PPy/PSS electrode in a similar fashion. The polymer-modified electrode was stimulated 
by switching its potential bias between -0.3 V, 0 V, and +0.3 V (Figure 22). 
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 The bipotentiostat system allows for two simultaneous electrical simuli to be 
applied to the same electrochemical system. The primary stimulation is the continuously 
sampling FSCV waveform, and the secondary stimulation is the electrical release 
stimulus indicated by the sharp current spikes (Fig. 22). 
 
 
Figure 22. Dynamic peak current of CFME in 10X PBS over time with electrical 
stimulation. This is the stimulus control for nanoporous and flat PPy/PSS modified 
electrodes. Stimulation of the GCD electrodes suddenly changes the equilibrium of the 
solution, resulting in artifacts visible from the FSCV in the form of vertical lines. 
 
 
3.4 Controlled Dopamine Release from Flat PPy/PSS Films 
 Electrical pulses at +0.3 V triggered the release of dopamine from flat PPy/PSS 
films. The experimental setup was configured according to Fig. 13A, so the time starts at 
400 seconds because the first half of the experiment required sampling a background 
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current without the PPy/PSS electrode present. Sampling for dopamine present in 
solution began at 400 seconds when 100µL of 1X PBS was added to the setup. Pulsatile 
electrical stimulation of the PPy/PSS modified electrode began at 500 seconds, and 
consisted of repeating intervals of 5 seconds of stimulation followed by 45 seconds of 0 
V. Convective currents are observed in the first few minutes, and increases in dopamine-
specific peak currents are observed following each stimulation artifact, immediately 
followed by a subsequent decrease in peak current (Figure 23). Overall, dopamine release 
from this electrically controlled system can be approximately quantified at 1.1 µM (~17 
ng in 100 µL). 
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A.  
B.  
Figure 23. (A) Dynamic background-subtracted cyclic voltammogram of pulsatile 
dopamine release from flat PPy/PSS modified GCD electrodes. Dopamine oxidation was 
characterized at +0.634 V (VPN ~211), and peak current at this potential was plotted (B). 
To prepare this electrode, dopamine (0.05 M) was cathodically bound to PPy/PSS by 
applying constant voltage of -0.6 V for 100 seconds. Time starts at 400 seconds because 
the experimental setup was configured as described in Fig. 13A, requiring replacement of 
the platinum electrode used for background with the PPy/PSS/DA modified GCD 
electrode. 
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3.5 Dopamine Release from Uncapped Nanoporous PPy/PSS Films 
3.5.1 Diffusion 
 Diffusion from PPy/PSS films, in the context of this thesis, can be described as 
the presence of dopamine in solution without an oxidative stimulus applied to the 
polymer film. In this sense, diffusion rather than electrochemical-mediation as a mode for 
release was seen from all PPy/PSS films in varying degrees. In uncapped nanoporous 
PPy/PSS films, dopamine release via diffusion was prevalent (Figure 24). 
 
 
Figure 24. Dynamic background-subtracted cyclic voltammogram illustrating dopamine 
diffusion over time from a nanoporous PPy/PSS film. Dopamine oxidation peak current 
is identified by the contour of the maximal red crest, occurring at +0.631 V (VPN ~210). 
The PPy/PSS modified electrode held at a bias of 0 V vs Ag/AgCl. 
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 Dopamine diffusion from nanoporous PPy/PSS films was analyzed when the 
polymer-modified electrode was held at a bias of -0.3 V vs Ag/AgCl. The solution was 
sampled with FSCV until the peak current reached an assumed plateau of equilibrium. 
Diffusion as a function of potential bias of the nanoporous PPy/PSS modified electrode 
was compared (Figure 25). Overall release of dopamine from diffusive mechanisms can 
be estimated at 2.1 µM and 5.3 µM (~64 ng and ~160 ng) for the polymers held at 0 V 
and -0.3 V respectively. Diffusion from the uncapped nanoporous PPy/PSS film at -0.3 V 
bias was analyzed a second time over a longer timescale. Peak currents were recorded 
until the release profile reached a plateau indicating steady state equilibrium. The 
dopamine released from the uncapped nanoporous polymer film via diffusion at -0.3 V 
bias is estimated at 4.5 µM (~138 ng).  
 
Figure 25. Peak current at dopamine oxidation potential detecting diffusion of dopamine 
from uncapped nanoporous PPy/PSS as a function of bias of the GCD electrode (n=1 for 
0 V bias, n=2 for -0.3 V bias). 
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3.5.2 Electrically Controlled Release 
 Nanoporous PPy/PSS films loaded with dopamine were rinsed in 10X PBS for 
varied periods of time at a potential bias of either 0 V of -0.3 V vs Ag/AgCl. This is 
meant to encourage diffusion, or uncontrolled release, of any loosely adhered dopamine 
until it is no longer observed, thereby ensuring that dopamine remaining in the film to be 
released later is done so in a controllable fashion. The electrical stimulus controlling 
release was toggled from its potential bias to +0.3 V in a series of pulses. Dopamine 
release was observed after application of +0.3 V stimuli as evidenced by peak currents at 
the oxidation potential of dopamine that increased much more than the stimulus control 
(Figure 26). 
 
Figure 26. Dynamic profiles of dopamine peak currents vs time from nanoporous 
PPy/PSS films.  
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3.6 Dopamine Release from Capped Nanoporous PPy/PSS 
 Nanoporous PPy/PSS films were capped with an additional layer of PPy/PSS as 
described in section 2.2. In an effort to incorporate dopamine within the nanoporous 
structure of the capped nanoporous film, the GCD electrode was reduced to cathodically 
bind dopamine through the semi-permeable cap. Dopamine release from both diffusive 
and electrical mechanisms was quantified. 
 
 
3.6.1 Diffusion 
 Dopamine diffusion from the capped nanoporous PPy/PSS film on GCD 
electrodes held at a -0.3 V bias was recorded until the peak current was observed to 
plateau at steady-state equilibrium. Dopamine diffusion from the capped nanoporous 
PPy/PSS film was estimated at 40.8 µM (~1250 ng). The peak current vs time plot is 
shown in Figure 27. 
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Figure 27. Peak current at dopamine oxidation potential to detect diffusion from 
nanoporous PPy/PSS films capped with an additional layer of PPy/PSS as a function of 
time.  
 
3.6.2 Electrically Controlled Release 
 After dopamine release from diffusion subsided to steady state, the capped 
nanoporous PPy/PSS films with dopamine were subjected to pulses of +0.3 V as 
described in section 2.6. The resulting peak current vs time plot is shown in Figure 28. 
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Figure 28. Change in peak current at dopamine oxidation potential as a function of time 
for capped nanoporous PPy/PSS film after diffusion. Background current was defined as 
the current recorded after dopamine diffusion in solution. 
 
 
3.7 Summary of Dopamine Release from Polymer Films 
 Dopamine release from the various mechanisms described in the previous sections 
was quantified and compared as shown in Figure 29.  
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Figure 29. Dopamine release from the various substrate electrodes via diffusive and 
controlled release mechanisms. Diffusion from the capped nanoporous film at -0.3 V (not 
shown) released 1250 ng of dopamine. Error bars indicate standard deviation, sample size 
is n=1 for both uncapped nanoporous diffusion at 0 V and flat controlled release, and n=2 
for both uncapped nanoporous controlled release and uncapped nanoporous diffusion at -
0.3 V. 
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4.0 DISCUSSION 
 
 Successful controlled release of dopamine from conducting polymers offers a 
compelling opportunity for clinical treatment of neurological disorders. Even more 
promising is the applicability of this controlled release system to a wide range of 
pharmaceutical compounds of interest. Dopamine is inherently highly unstable, and 
successful characterization of its release from conducting polymers with its molecular 
structure intact suggests that the electrical release system will not affect the biological 
functionality of more resilient molecules.  
 At this point, it is clear that the original aims of this study have not been met in 
entirety. This project is intended to electrochemically bind and release dopamine from the 
conducting polymer while maximizing the carrying capacity, minimizing dopamine 
leaking out due to diffusion, and preserving the biological functionality of the released 
dopamine. Instead, the two polymer systems developed satisfy several of these aims to 
varying degrees. 
 
4.1 Cathodic Binding of Dopamine 
Dopamine binding to the conducting polymer films is a process that is 
theoretically plausible and has been verified experimentally [26, 27]. Experimental 
validation of this process runs in concert with verification of electrically controlled 
release. Quantification of changes in mass of the modified electrode surface during 
cathodic binding of dopamine was not performed. Therefore, it is assumed that the 
process of electrostatic binding of dopamine to the polymer film is a prerequisite to 
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controlled release, i.e. controlled release of dopamine cannot happen without it binding 
cathodically first. If this assumption is correct and no other interactions are responsible 
for controlled release of cationic drugs, these findings corroborate past experimental 
evidence. 
Incorporation and release of cations from conducting polymers is mechanistically 
more complex than traditional doping that is seen in anionic drug release systems (Fig. 
2,3). As such, the electrochemical process of loading cationic drugs into conducting 
polymers must sequentially follow electropolymerization of the polymer itself, whereas 
anionic drugs are loaded into the polymer film during its synthesis. The separation of 
theses two processes offers a further degree of freedom in the customizability of a 
controlled release system, as well as another potential area for complications.  
Typically the monomer and dopant concentrations, parameters of 
electropolymerizeration, and morphology of the substrate electrode have profound effects 
on the conductivity, actuation ability, and structure of the polymer film. These three 
polymer properties can significantly change the characteristics of drug release. 
Conductivity and surface area of the film are related to how effectively the polymer can 
charge and discharge and interact with the loaded drug to electrostatically drive its 
release. Actuation, or movement of the polymer, helps to drive drug release during its 
swelling and contracting with ionic flux.  
In a cationic loading and releasing mechanism, the disconnection between the 
drug loading and polymer synthesis processes can lead to less intimate electrostatic 
interactions between the drug and the polymer compared to doping. However, the process 
of cathodic binding of the drug to the film offers another degree of freedom with the type 
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of electrochemical process used for loading. For example, slow cyclic voltammetry might 
prove to be more effective to load cationic drugs to conducting polymer films than 
constant current because of the repetitive pumping of the polymer that this method 
affords. Therefore, while the experimental evidence supports the notion that constant 
reductive potential binds dopamine to the polymer film, other electrochemical methods 
could result in more effective electrostatic interactions between the cationic drug and the 
polymer. This suggests that less dopamine would be released from diffusion, ultimately 
leading to a more controllable mechanism of release. 
Cathodic binding of dopamine to the conducting polymer is a function of the 
redox capabilities of the polymer itself. In this study, the potential used to bind dopamine 
was -0.6 V, whereas the polymer was more fully reduced at a potential of -0.7 or -0.8 V 
as shown by the position of the reduction peak in the cyclic voltammogram of the 
PPy/PSS film (Fig 20). While dopamine was observed to cathodically bind to the 
polymer film, a possible reason for it to bind less completely is that the conducting 
polymer was not sufficiently reduced to fully drive electrostatic incorporation of 
dopamine into the film. This is one possible contributing factor to the high quantities of 
dopamine diffusion that are especially prevalent in the nanoporous structure. 
 
4.2 Dopamine Release 
The processes of diffusion and electrically controlled release are strongly 
connected to the amount of drug loaded into the film. Consequently, it is difficult to 
discuss the release processes as independent of the drug capacity of the polymer. As the 
structure implies, nanoporous polymer films have been shown to carry much more drug 
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than their non-nanoporous counterparts [19, 29]. However, this increased capacity also 
stems from a fundamentally different relationship between the loaded drug and the film 
than in the non-nanoporous case. While the electrostatic binding process occurs to 
incorporate dopamine into both polymer films, the data indicating extensive diffusion 
from the nanoporous films suggest more of a reservoir-type drug storage mechanism. 
Simply put, more dopamine can be stored in the nanoporous film because there is much 
more space for it to occupy. The added consequence of this nanoporous structure is that 
the dopamine leaks out almost as easily as it was incorporated (Fig. 25), leaving much 
less dopamine available for electrically controlled release (Fig. 26). In fact, while more 
dopamine was incorporated into the nanoporous film than the flat film, the amount of 
dopamine observed by controlled release was below the detection limit of the carbon-
fiber microelectrode.  
Diffusion at different potential biases from nanoporous PPy/PSS films yielded 
results that are, at first glance, counterintuitive to our understanding of the redox binding 
and release mechanism of conducting polymers. The conventional opinion of this 
mechanism for cationic drugs is that reduction of the polymer promotes binding and 
retention of drug in the film, and oxidation of the polymer triggers release. The expected 
result would therefore be dopamine diffusion from the polymer that is inhibited by lower 
potentials. Yet it is important to acknowledge that the degree of oxidation and reduction 
of the polymer is not linearly proportional to its potential bias. The oxidation and 
reduction peaks (Fig. 20) indicate the potentials at which oxidation and reduction are 
favored (approximately 0 V and -0.7 V respectively). With this in consideration, the 
diffusion observed from the polymer at 0 V bias should not be substantially more than 
51 
 
that observed from the polymer at -0.3 V. However, over twice as much dopamine was 
released from the nanoporous polymer held at -0.3 V than the nanoporous polymer at 0 
V. This result is likely caused by experimental error and a more rational relationship will 
likely result from repeated trials. 
The most intriguing aspect of these diffusion results at negative potential bias is 
the delay in drug release. It appears that holding the dopamine-bound electrode film at a 
negative potential inhibits the passive release of dopamine from the film (Fig. 25). In 
these two trials, dopamine was retained for 100-200 seconds before it started to leak out 
of the film. This offers a very promising direction for future research in controlled 
release. However, this retention of dopamine was not indefinite. After 100-200 seconds, 
dopamine began to diffuse from the polymer, the underlying reasons for which are 
currently unknown and must be investigated further. The variability in diffusion profiles 
observed from these two uncapped nanoporous films is probably due to differences in 
positioning of the CFME relative to the releasing electrode. Still, the overall effect is the 
same. Both electrodes exhibit a delay of dopamine diffusion, and both electrodes release 
very similar quantities of dopamine over the course of this diffusion process. 
Substantially less diffusion of dopamine was observed from the release profile of 
the flat PPy/PSS films (Fig. 23B, 400-500s). Though this process was not tested 
thoroughly, repeating cycles of rising and falling peak currents are likely attributed to 
convective fluid flow within the droplet as the 1X PBS solution was added. This inability 
to effectively quantify diffusion was one of the shortcomings of the initial experimental 
configuration and motivating factors to reconfigure the setup (Fig. 13A). Still, electrically 
controlled release was observed after each applied stimulus (+0.3 V pulses), recognized 
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by a local increase and decrease in peak current after each stimulus. Long-term decay of 
peak current after several stimulations is explained by diffusion of the electrically 
released dopamine throughout the solution over time (Fig. 23B). The advantage of this 
setup is the minimal distance between the polymer-modified electrode and the CFME 
positioned 250 µm opposite its surface, providing highly responsive temporal resolution 
of release that is not reproduced by the other experimental configurations. 
 
4.3 Dopamine Release from Capped Nanoporous Films 
While the ultimate aim is to maximize controlled release while minimizing 
diffusion, it seems as though the opposite trend pervades the existing system of drug 
release based on nanoporous conducting polymers One approach to minimizing the 
extensive diffusion without reducing the amount of dopamine loaded would be to 
incorporate a semipermeable cap. Electropolymerization of this cap poses additional 
challenges, but the electrochemical properties of the cap should mimic the behavior of the 
traditional, non-nanoporous polymer film in conductivity, permeability, and actuation. 
The preliminary studies of dopamine incorporation and release from capped 
nanoporous films suggest a number of processes that are less than ideal for controlled 
release mechanisms. Several caps of different permeabilities for the nanoporous film 
were previously developed by varying the scan rate of electropolymerization, and drug 
release from these capped nanoporous films was studied. The most permeable cap was 
used for this thesis because it needed to allow dopamine to first pass from solution into 
the nanopores before it could be subsequently released from the nanopores, through the 
cap once more, and into solution. While prior research focuses on capping the 
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nanoporous film after the drug already incorporated into the nanopores [19, 29], this 
capping process would oxidize the bound dopamine into the quinone, rendering it 
physiologically irrelevant, described in greater detail in section 4.5. 
The data from this type of electrode show extensive diffusion of dopamine that 
greatly exceeds drug release from any of the other polymer films, almost by a full order 
of magnitude (Fig 27, 29). After diffusion, the release profile from electrical stimuli 
shows not only a lack of dopamine release, but also a decay in peak current (Fig 28). 
These data are consistent with the expected behavior of the electrode if the dopamine 
never permeated the polymer cap in the first place. The extensive diffusion is likely the 
result of loose adhesion of dopamine cathodically bound to the outer layer of the polymer 
cap. Despite the implementation of the most permeable polymer cap, no dopamine 
release was observed upon application of the oxidative electrical command stimulus. The 
decrease in peak current observed from the pulse train is most probably attributed to 
either continued equilibration of the CFME, or continued diffusion of higher 
concentrations of dopamine from the region of the droplet with the electrodes to the outer 
edges. 
This ineffective application of the polymer cap for dopamine release from 
nanoporous films can be approached several ways. First, further optimizing the 
permeability of the polymer cap should be possible by varying the parameters of its 
electrochemical synthesis. If that proves unsuccessful, polymer-based switches and gates 
could be implemented to physically permit or inhibit the release of dopamine from the 
electrode by implementing the unique property of electrically driven actuation for 
conducting polymers. Another possible solution would be to incorporate an active 
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reductant into the nanoporous polymer film with dopamine prior to capping. This would 
allow dopamine to be released with its structure preserved, due to the reductant becoming 
oxidized rather than dopamine. 
 
4.4 Limitations of Experimental Setup 
 As explained previously, electrical release is governed by the oxidation and 
reduction of the polymer. The optimization of the electrical signal that causes this 
oxidation and reduction of the polymer backbone is therefore critical to designing the 
controllability of the release. In the current experimental setup, the electrical stimulus 
applied to the polymer-modified electrode is determined by flipping a toggle switch that 
applies a predetermined potential in either the anodic or cathodic direction. As such, the 
magnitude of the release stimulus is limited to this predetermined potential (in either 
direction) and the rest potential (0 V). The flexibility of the release stimulus is further 
constricted to voltage pulses as opposed to other electrical waveforms that may prove to 
be more effective in releasing dopamine from the polymer. 
 Accurate and reliable quantification of dopamine is absolutely critical for the 
successful execution of this project, especially for the low concentrations of dopamine 
that are relevant for this study and even lower concentrations that are clinically 
significant. Fast-scan cyclic voltammetry with carbon-fiber microelectrodes is the 
analytical method of choice for detection of dopamine and other catecholamines in vivo. 
For in vitro dopamine studies of this nature, however, other factors complicate this 
relatively straightforward electroanalytical method of analysis. 
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One issue that arose was the positive drifting of the oxidation potential where 
dopamine oxidation was observed within the same release (or diffusion) trial. Two 
potential causes of this are the superposition of a dynamic equilibration curve, and 
shifting solution pH. Since each trial of electrically controlled dopamine release requires 
many minutes of data recorded at 10 Hz, it is possible that the background curve of the 
CFME changed significantly over this period of time. Superposition of this changing 
background curve due to CFME equilibration (Fig. 17) on top of the actual dopamine 
signal could potentially cause the oxidation potential of dopamine to drift within a release 
trial. Therefore, ample time was given for the CFME to equilibrate to steady state 
beforehand (Fig 18). The other potential cause of peak shifting is a change in solution pH 
over the course of a release trial generated from the protons present in the characteristic 
redox reaction of dopamine (Fig. 6). The buffer solution was changed from 1X PBS to 
10X PBS to better neutralize any acidic or basic byproducts. 
Clinically relevant dopamine concentrations run several orders of magnitude 
smaller than the dopamine concentrations observed in this system. Additionally, 
calibration sensitivity of carbon-fiber microelectrodes for catecholamine detection has 
been shown to vary dramatically between solvents. The data suggest that carbon-fiber 
microlectrodes are less sensitive to dopamine in 10X PBS than in ACSF (Fig. 15). The 
same relationship is experimentally supported in the detection of other catecholamines 
using CFMEs as well [64]. While the concentrations of dopamine for this in vitro study 
are much higher than typical in vivo levels, the strong 10X PBS buffer that this 
experiment requires to avoid solution pH shifts may possibly be limiting the capacity of 
the electrode to detect dopamine. This is supported by the post-diffusion controlled 
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release data from the nanoporous films (Fig. 26). A dynamic increase in dopamine 
oxidation peak currents was observed while the net change (+20 nA) was still under the 
detection limit of that specific CFME when the dopamine calibration was fit to a linear 
curve. 
Linearity may not be an appropriate assumption for the trend of peak currents 
versus dopamine concentrations for the range of calibration. The carbon surface substrate 
is highly conducive to dopamine adsorption, and this adsorption is supposed to increase 
dopamine sensitivity [65]. The sensitivity of the CFMEs can therefore be described as a 
function of dopamine adsorption. Calibration of the CFMEs to standardize peak currents 
to dopamine concentrations served the secondary purpose of pre-exposing the CFMEs to 
dopamine prior to release quantification. Pre-exposure of the CFMEs to dopamine is 
designed to control dopamine adsorption to a stable level. This thereby ensures a stable 
calibration that is less significantly altered by the presence of dopamine from the 
controlled release system. While linear relationships are generally used to calibrate 
CFMEs for the dopamine detection, it is essential that the range of calibration 
concentrations include the entire range of dopamine concentrations that are observed 
while detecting dopamine release in this system. Dopamine adsorption alters this 
calibration curve. The accuracy of the calibrated fit against the expected theoretical 
relationship between concentration and peak current has yet to be explored. 
Another potential source of complication for the CFME arises from inserting a 
large disk electrode into a system typically used for CFMEs alone. When the potential of 
the PPy/PSS modified GCD electrode changes, a spike in the cyclic voltammogram of the 
CFME is observed. While this phenomenon has consistently been referred to as an 
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“artifact,” this term is not entirely accurate. Labeling this as an artifact implies that there 
is some glitch in the bipotentiostat or data analysis equipment that falsely provided 
graphical representation of an event that actually did not occur, when this is simply not 
the case. The spike is the response of the CFME to the sudden change in current that such 
a comparably large electrode imparts onto the system. Practically, these spikes serve as 
visual markers to indicate the temporal location of the electrical release stimulus. 
Subjecting the CFME to frequent stimuli of high current could potentially alter its long-
term performance. However, the CFME seems unaffected in the short term and there is 
nothing to suggest this mode of electrode failure without further experimentation. 
  
4.5 Limitations with Dopamine 
The development of a conducting polymer system for dopamine release has been 
a process riddled with complexities. The chemical instability of dopamine has 
consequences that are both beneficial and challenging to this research. It is readily 
oxidized to dopamine-o-quinone, and fast-scan cyclic voltammetry capitalizes on the fast 
kinetics of this reaction, making electrochemical detection of dopamine very feasible. 
However, oxidation of dopamine otherwise causes a multitude of challenges.  
Autoxidation and autopolymerization of dopamine are processes that potentially 
complicate the incorporation within and release from conducting polymer films. 
Dopamine autoxidation is the first step to autopolymerization, in which dopamine reacts 
with molecular oxygen naturally in solution to ultimately form aggregates and precipitate 
out of solution. To inhibit this rapid process, dopamine solutions were kept under N2 for 
the period of time after they were mixed prior to use. However, it is unknown how much 
58 
 
of this reaction occurs before dopamine can be cathodically bound. It is assumed that 
dopamine rather than any of its oxidized products is incorporated into the conducting 
polymer film, verified by the position of the oxidation and reduction peaks observed on 
FSCV. Dopamine, readily oxidized in solution, may also have a significant fraction of its 
concentration existing as the quinone during release studies. If more dopamine exists as 
the quinone, the oxidation peak would not be as high as the reduction peak, and detection 
sensitivity would be decreased using the peak current at the oxidation potential. 
Another limitation of working with dopamine is the restrictions its instability 
imposes on the possible stimuli for the conducting polymer film. Dopamine typically 
oxidizes between +0.5 and +0.7 V. To retain the molecular structure and biological 
functionality of dopamine, the potential of the polymer should not approach these values 
where dopamine oxidation would render it biologically useless and potentially even toxic 
[43]. The potential of the electrical release stimulus was predetermined not to exceed 
+0.3 V to avoid this process.  
This has three implications on the behavior of the polymer. First, it does not allow 
for higher degrees of actuation of the polymer that higher potentials would cause, limiting 
the ability of the polymer to expand and contract to more effectively engage in ion 
exchange and subsequent dopamine release. Second, the slight +0.3 V potential may still 
be high enough to promote autopolymerization within the polymer film. 
Autopolymerization and aggregation of dopamine within the polymer film would 
drastically reduce the amount of dopamine available to release and inhibit the release of 
the dopamine that is available. Finally, electropolymerization of semipermeable polymer 
caps over nanoporous PPy/PSS/DA films to inhibit diffusion is no longer a feasible 
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option due to the sensitivity of dopamine to oxidative stimuli. Initiation of 
electropolymerization is typically done with potentials upwards of +0.7 V vs Ag/AgCl, 
which would oxidize dopamine contained within the film to the quinone. Therefore, 
capping the nanoporous conducting polymer film would have to precede cathodic binding 
of dopamine. The permeability of the cap would have to be optimal to allow dopamine to 
be pulled through in the binding process, but prevent excessive diffusion in the release 
process. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
60 
 
 
5.0 CONCLUSIONS AND FUTURE WORK 
 
 Electroactive conducting polymer films hold promise for the development of 
customizable, controllable drug release systems. The advantage of a nanoporous structure 
over a non-nanoporous structure of conducting polymers for electrically controlled 
dopamine release is greatly increased loading capacity. The primary mechanism of 
release was largely diffusion without any electrical stimulus, but electrically controlled 
release was observed in both flat and nanoporous conducting polymer films. Application 
of a reducing potential did not inhibit dopamine diffusion from the nanoporous polymer 
film.  
 Future work will focus on the development and optimization of the semi-
permeable cap to inhibit dopamine diffusion from the nanoporous film and mediate 
electrically controlled release. Higher resolution and wider range of concentrations for 
calibration of the carbon-fiber microelectrodes will be investigated. While electrically 
controlled release of dopamine was observed, further experimentation to minimize 
diffusion and maximize controllability must be explored. 
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